Dermata Therapeutics, Inc. (DRMA) Misses Q1 EPS by 27c
Tweet
Share
E-mailGet Alerts DRMA Hot Sheet
Join SI Premium – FREE
Dermata Therapeutics, Inc. (NASDAQ: DRMA) reported Q1 EPS of ($0.47), $0.27 worse than the analyst estimate of ($0.20).
For earnings history and earnings-related data on Dermata Therapeutics, Inc. (DRMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
- Adobe (ADBE) PT Raised to $315 at RBC Capital
- Scotiabank Starts Block Inc. (XYZ) at Sector Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
